UBS Group set a €53.00 ($61.63) target price on Lanxess (ETR:LXS) in a research report sent to investors on Monday, February 4th, www.boersen-zeitung.de reports. The firm currently has a neutral rating on the stock.
Other equities research analysts have also issued reports about the company. Nord/LB set a €62.00 ($72.09) target price on Lanxess and gave the company a buy rating in a research report on Monday, November 12th. Goldman Sachs Group set a €84.00 ($97.67) target price on Lanxess and gave the company a buy rating in a research report on Monday, November 12th. Kepler Capital Markets set a €86.00 ($100.00) target price on Lanxess and gave the company a buy rating in a research report on Monday, November 12th. Warburg Research set a €79.00 ($91.86) price target on Lanxess and gave the company a buy rating in a report on Tuesday, November 13th. Finally, Cfra set a €65.00 ($75.58) price target on Lanxess and gave the company a buy rating in a report on Tuesday, November 13th. Three investment analysts have rated the stock with a sell rating, twelve have given a hold rating and nine have assigned a buy rating to the stock. Lanxess has an average rating of Hold and a consensus price target of €62.26 ($72.40).
Shares of LXS stock traded up €1.23 ($1.43) on Monday, reaching €48.88 ($56.84). 260,897 shares of the company’s stock were exchanged, compared to its average volume of 312,027. Lanxess has a 52 week low of €59.89 ($69.64) and a 52 week high of €74.50 ($86.63).
Lanxess Company Profile
LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.
Recommended Story: What type of investment options does a Roth IRA provide?
Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.